LYRA THERAPEUTICS ($LYRA) posted quarterly earnings results on Tuesday, August 12th. The company reported earnings of -$5.51 per share, beating estimates of -$6.14 by $0.63. The company also reported revenue of $180,000, beating estimates of $174,675 by $5,325.
You can see Quiver Quantitative's $LYRA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LYRA THERAPEUTICS Insider Trading Activity
LYRA THERAPEUTICS insiders have traded $LYRA stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $LYRA stock by insiders over the last 6 months:
- MARIA PALASIS (President & CEO) sold 1,565 shares for an estimated $13,944
- JASON CAVALIER (Chief Financial Officer) sold 684 shares for an estimated $6,094
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
LYRA THERAPEUTICS Hedge Fund Activity
We have seen 15 institutional investors add shares of LYRA THERAPEUTICS stock to their portfolio, and 14 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SAMSARA BIOCAPITAL, LLC removed 575,559 shares (-29.3%) from their portfolio in Q1 2025, for an estimated $72,693
- QUBE RESEARCH & TECHNOLOGIES LTD removed 342,159 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $43,214
- GOLDMAN SACHS GROUP INC removed 185,314 shares (-33.4%) from their portfolio in Q1 2025, for an estimated $23,405
- MORGAN STANLEY removed 150,866 shares (-69.7%) from their portfolio in Q1 2025, for an estimated $19,054
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 114,137 shares (+110.4%) to their portfolio in Q1 2025, for an estimated $14,415
- SEI INVESTMENTS CO removed 54,008 shares (-64.2%) from their portfolio in Q1 2025, for an estimated $6,821
- NORTHERN TRUST CORP added 46,329 shares (+16.2%) to their portfolio in Q1 2025, for an estimated $5,851
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
